Aion Healthspan, Inc.
Clinical trials sponsored by Aion Healthspan, Inc., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New infusion drug AION-301 aims to slow kidney disease progression Results expected Jan 2027 (estimated)